A Review of Coccidioides Research, Outstanding Questions in the Field, and Contributions by Women Scientists

Purpose of Review Coccidioidomycosis is an infectious disease that gained clinical significance in the early 20th century. Many of the foundational contributions to coccidioidomycosis research, including the discovery of the fungal disease agent, Coccidioides spp., were made by women. We review recent progress in Coccidioides research and big questions remaining in the field, while highlighting some of the contributions from women. Recent Findings New molecular-based techniques provide a promising method for detecting Coccidioides, which can help determine the dominate reservoir host and ideal environmental conditions for growth. Genetic and genomic analyses have allowed an understanding of population structure, species level diversity, and evolutionary histories. We present a current, comprehensive genome list, where women contributed many of these entries. Several efforts to develop a coccidioidomycosis vaccine are underway. Summary Women continue to pioneer research on Coccidioides, including the relationships between the fungi and the environment, genetics, and clinical observations. Significant questions remain in the field of Coccidioides, including the main host reservoir, the relationships between genotypic and phenotypic variation, and the underlying cause for chronic clinical coccidioidomycosis cases.


Introduction
Since the early twentieth century when coccidioidomycosis gained clinical significance, women have made significant contributions to the advancements in understanding this disease. Many of the foundational studies on the environmental, genetic, and clinical aspects of coccidioidomycosis have been led by women, including the identification of the causative fungal pathogen, Coccidioides spp. In 1934, Dr. Myrnie Gifford, an assistant health officer for Kern County, California, was the first physician to investigate a Californian disease called "San Joaquin Valley fever" (the origins of its colloquial name, Valley fever). She proved that Coccidioides was the causative agent for Valley fever and continued to observe clinical and epidemiological outcomes throughout her career [1][2][3][4]. This initial connection between the causative agent and resultant Coccidioides infection provided a clear target for future research endeavors and immediately helped raise awareness about the risk for coccidioidomycosis, especially in California's Central Valley.
As the foundational knowledge about Coccidioides continued to grow, women approached the need to understand what communities may be at risk for coccidioidomycosis infection. Starting in the mid-1940s, Dr. Phyllis Edwards, in collaboration with Dr. Caroll Palmer, conducted a seminal This article is part of the Topical Collection on Mycology * Morgan E. Gorris mgorris@lanl.gov seroprevalence study among young, healthy volunteers to establish the first Coccidioides endemic map [5]. Conducted between 1945 and 1951, over 110,000 Navy recruits, student nurses, and college students were enrolled in this coccidioidin skin testing study that led to the first known map of disease distribution across the USA. Prior to this research, little was known about the disease outside of specific areas of California, Arizona, New Mexico, and Texas [6][7][8].
In addition to determining where coccidioidomycosis infection is likely to occur, women have also significantly contributed to understanding the clinical outcomes of this disease. While the majority of coccidioidomycosis cases are asymptomatic, the predominant manifestation is primary pulmonary disease in the form of pneumonia [9]. Overall, the disease tends to impact men more than women [10]. However, in recent years, Dr. Rebecca Sunenshine and colleagues analyzed case data in Arizona from 2009 to 2015 and found a slight female predominance [11]. Race is also a factor in increased risk of infection; BIPOC (black, Indigenous, and people of color) women are at greater risk than white women to develop disseminated disease (organ involvement outside of the lungs) and require hospitalization [12,13]. Accounting for level of exposure, race alone does not confer an inherent increased risk to inhale the arthroconidia of Coccidioides; occupation, access to and quality of health care, and a variety of research-related bias contribute to this paradigm [12]. Pregnancy is not only a risk factor for coccidioidomycosis, but also for more severe manifestations [14][15][16][17]. Acquisition of the disease during pregnancy, especially during the third trimester and postpartum period, increases the likelihood of poor outcomes, including death [14,18,19]. Depending on the timing of acquisition during pregnancy, the percent likelihood of disease dissemination ranges from 10 to 96% [15,17].
Though sometimes overlooked or under cited for their contributions, women have made and continue to make significant achievements in understanding Coccidioides and coccidioidomycosis. We provide an overview of some of the contributions of women to the field of Coccidioides, emphasizing past contributions, current research, and big questions remaining for the field (Figure 1). In addition to specifically naming the women associated with certain contributions, we endorse the claims made throughout our review using many studies led and supported by women.

Environment
Several questions remain regarding the environmental conditions conducive to the presence of Coccidioides and areas of enhanced risk for contracting coccidioidomycosis, including the dominant reservoir host, favorable soil properties, and ideal climate conditions [20]. Answering these questions has been difficult due to the challenge of acquiring environmental samples of Coccidioides. New molecular-based techniques provide a promising method for detection, which could accelerate research in this area.

The Coccidioides Host Reservoir
An exact host reservoir for Coccidioides has partially eluded researchers. It has become evident over recent decades that Coccidioides depends on animal species in order to maintain its life cycle [21, 22••]. Comparative genomic studies emphasized a shift from plant tissue-associated genes to animal tissue-associated genes by discovering a significant decrease of genes involved in cell wall degradation (cellulase, tannase, cutinase, and pectin lyase) paired with an expansion of proteases and keratinases suggesting a nutritional association with mammals [23,24]. A revival of research from the 1940s [25,26] has steered researchers' attention to rodents and their burrows as the main hypothesis for a dominant host reservoir. Multiple studies have exhibited a higher percentage recovery of Coccidioides from soil collected from rodent burrows than from surrounding topsoil [27][28][29]. Early on, an experiment performed by Maddy and Crecelius (1967) buried mice that were experimentally infected with Coccidioides in endemic soils that had previously failed to produce cultures of C. immitis for 3 years. Five months after the burial, that soil produced a positive culture and remained positive for 6 subsequent years of investigation, demonstrating sporulation of Coccidioides in the carcasses of dead rodents [30]. Even if rodents are the correct hypothesized dominant reservoir, Rodentia is still the most diverse order within Mammalia, encompassing 2,590 species within 521 genera [31]. Very little research has been conducted to pinpoint a dominant host genus or species. It is possible, if not likely, that C. immitis and C. posadasii may be specialized for different host reservoirs, which could vary by geographical region. One species of interest for further investigation in the southwestern US is the desert woodrat (Neotoma lepida), whose presence significantly overlaps with human coccidioidomycosis cases [32].
Although current hypotheses suggest that rodents are the predominant host reservoir, Coccidioides has been detected in a diverse array of wild mammals including bats [33], armadillos [34], sea lions and sea otters [35], llamas and alpacas [36], and numerous non-native zoo animals [21]. The presence of Coccidioides in both terrestrial and marine mammals, as well as volant mammals, suggests that fungal dispersion could take multiple avenues with the migration of their commensal hosts. Coccidioides, present even in low abundance in the lungs [37], may be adapted to proliferate on hair, skin, nails/hooves, and bones of carcasses [38]. This supports an eventual shift in the fungal burden from the host back to the soil; in turn, this maintains the modality of Coccidioides being dispersed by wind or soil disturbance and thus the inhalation of arthroconidia into future hosts. This cycle, in part, could supplement the explanation of a geographic range expansion of Coccidioides associated with human migration [39].

Soil, Environmental, and Climatic Conditions
In addition to the presence of important host reservoirs, certain soil conditions may be favorable habitats for Coccidioides. Drs. Ann Elconin and Margret Egeberg highlighted the significance of studying physical soil properties such as alkalinity and salinity, which may explain some of the heterogeneity in the presence of Coccidioides within each microenvironment [28,40]. However, recent correlations between soil properties and the presence of Coccidioides have been inconsistent across studies, making it challenging to draw definitive conclusions. For example, soil properties have been the same where both positive and negative Coccidioides samples were collected [41]. Dr. Antje Lauer and colleagues continue to explore the potential for alkaline soils and the associated vegetation, as well as sandy loam soil textures, to be a favorable soil microenvironment for Coccidioides [42,43]. In addition to abiotic factors, biotic factors such as microbial competition may also be an important determinant for the presence of Coccidioides [21]. Parsing the differences in preferential abiotic and biotic soil environments between C. immitis and C. posadasii would help disentangle any differences in the geographical distribution of these pathogens.
Climate conditions also likely determine the timing and amount of Coccidioides growth within endemic soils.
Coccidioides is thought to proliferate following wet conditions; then if stressed by hot and dry conditions, it will autolyze into arthroconidia that may be easily dispersed by the wind [44]. Although it has not been possible to study this mechanism at the microbial level, human cases of coccidioidomycosis have been correlated with lagged climatic conditions, where cases were higher following dry and warm months [45]. In southern Arizona, temperatures in the preceding season have had a significant positive relationship with coccidioidomycosis incidence [45]. In the San Joaquin Valley of California, autumn levels of human coccidioidomycosis incidence have been higher following cooler and wetter winter and spring months [46,47]. Not only do climate conditions affect the seasonal pattern of disease incidence, but they can also modulate the interannual variation in the number of disease cases [45,46], though this relationship is less clear. Taken in combination, considering the effects of climate conditions with demographic and health risk factors provides a method of calculating a vulnerability index for coccidioidomycosis [48], which can help identify communities most at risk for contracting this disease.

The Geographical Distribution of Coccidioides
Together, the host reservoirs, soil environment, and climate conditions likely structure the environmental niche and therefore geographical distribution of Coccidioides. Dr. Meritxell Riquelme's lab has been at the forefront of examining where Coccidioides lives in the environment. This is imperative to understanding the risk of coccidioidomycosis, especially if the geographical distribution shifts in response to climate change [49]. Soil samples positive for Coccidioides, human coccidioidomycosis case data, and important environmental drivers paired with ecological niche models have made it possible to create high-resolution estimates of the Coccidioides endemic region [32, 50, 51••]. Using human coccidioidomycosis data as a proxy for Coccidioides presence, Dr. Morgan Gorris and colleagues predict that by the end of the twenty-first century, warming temperatures across the dry, western US may cause the endemic region to expand north [51••]. This may cause a large increase in the number of people at risk for contracting coccidioidomycosis, the subsequent number of disease cases, and the financial burden of this disease [52]. In contrast, a separate analysis using Coccidioides presence data in a niche model found that by 2070, the geographical distribution of Coccidioides may contract, but the habitat suitability within already suitable locations will increase [32]. Continued disease surveillance and soil sampling will help to further resolve the ecological niche of Coccidioides and discrepancies between estimates, especially as we identify new endemic areas, such as Washington State [53,54]. By identifying differences between Coccidioides species, like thermotolerance [55•], we can also determine if there is a niche unique to each species. This will help to delineate the geographical distribution of each species, which may be different than originally thought; for example, C. immitis, originally deemed the "California species," has also been found in New Me xic o, U ta h, an d Wa shi ngt on [5 3, 56 , 57] . Understanding the distribution of Coccidioides will help with assessing human risk for coccidioidomycosis and identifying locations prone to disease outbreaks from activities with large soil disturbance like agriculture, construction, or natural hazards like wildfires, dust storms, and landslides from earthquakes [41,[58][59][60][61][62].
In many ways, future research of Coccidioides is dependent on acquiring environmental samples to supplement clinical and veterinary samples. Although C. immitis can be cultured directly from soils, it has proven difficult with one study only obtaining 0.55% (4 out of 720) success in a known endemic range of California [63]. For C. posadasii, which has not been directly cultured from soil, Dr. Bridget Barker and collaborators demonstrated that detection is possible using BALB/c mice as biosensors in soils near Tucson, Arizona, with a 8.9% positive detection rate [64]. Intraperitoneal inoculation into mice was also successful in isolating C. posadasii from six out of 24 (25%) soil samples from Brazil [65]. A promising, new detection tool developed by Drs. Jolene Bowers and Bridget Barker is the CocciENV real-time PCR assay, which provides a robust way to test a large number of soils for Coccidioides DNA [66]. Although not commonly used in practice, molecular-based technologies exist to differentiate the two species, which may become more essential as we tease apart phenotypic differences [56,67].

Coccidioides Genetics
Since the early 1990s, scientists have used classic genetics, and later genomics, to study Coccidioides. Notable contributing researchers include Dr. Bridget Barker, Dr. Chiung-Yu Hung, Dr. Clarisa Nobile, and Dr. Emily Whiston. Together, they and their colleagues have produced a seminal body of research literature identifying key virulence genes and elucidating the role of genetic systems. In parallel, they have utilized and developed a genetic tool kit including genome sequences and editing tools to continue exploring the molecular underpinnings of Coccidioides virulence.
Phenotypic and molecular studies have long suggested that Coccidioides populations differ by region and disease manifestation. There are at least two species of Coccidioides in Western North America, Central America, and South America and the genomic variation within isolates within those sub-populations that can be leveraged to answer longstanding questions about the variable effects of coccidioidomycosis isolates in humans and animals.

Populations and Variance in Genomes
Genetic and genomic analyses have allowed an understanding of population structure, species level diversity, and evolutionary histories. Better understanding the molecular diversity of Coccidioides and how past evolutionary selective pressures have resulted in current molecular virulence mechanisms will greatly expedite novel therapeutic strategies for treating Coccidioides. Though C. posadasii was originally described in 1896, it was not until 2002 when microsatellite and ITS sequence data were available that C. immitis and C. posadasii were differentiated [39]. Since then, we have gained appreciation for substantial intraspecific C. posadasii population structure in Texas, Mexico, and South America [22••], and that Arizona has the most diverse isolates of C. posadasii. This is reflected in the asymmetric-genome sequence availability of C. posadasii and C. immitis isolates, many of which were contributed by women (Table 1). Whole-genome sequencing of over 30 new isolates [68] shows that Coccidioides likely originated in the Sonoran Desert.
Whole-genome sequence analyses in Caribbean Coccidioides populations suggest that isolates in Venezuela and surrounding areas have been subjected to a recent bottleneck, and thus their populations are less diverse than their conspecific counterparts with more northern distributions [71]. This molecular diversity distribution pattern across geographical space reinforced earlier findings using a microsatellite marker approach by Fisher et al. [39] suggesting that South  American populations are younger and less diverse. C. posadasii spread to South America 9,000-14,000 years ago, concomitant with human migration patterns and was potentially disseminated by our infected ancestors. While there are fewer genome sequences available and less molecular diversity within C. immitis (Table 1), population analyses suggest that there are at least two sub-populations, one in Washington State and the other in Central and Southern California [53,71]. In their overlapping geographic regions in Southern California and Northern Mexico, we observe signals of introgression between C. immitis and C. posadasii including within the well-studied isolate C. immitis RS. Several considerations should be taken by future researchers when analyzing Coccidioides genomic data. First, they should take care to note potential hybridized isolates and the implications for variant identification when selecting reference genomes for alignment-based inferences. Second, while many Coccidioides sequences are available on the NCBI Short Read Archive (SRA), a few assemblies including C. immitis RS, C. posadasii C735, and Silveira are only on the NCBI database (Table 1). Last, there are several Coccidioides isolates that have been published under multiple strain names ( Table 1). The genome sequencing era has provided ample opportunity to utilize long-standing tools from evolutionary biology to gain insight into Coccidioides virulence genetics, providing targets for novel therapeutic design. Cross disciplinary approaches utilizing whole genome sequencing data, evolutionary genomics, and species level diversity are likely to continue unraveling how fungal genomic diversity contributes to our complex interactions with Coccidioides.

Phenotypic Variation
Coccidioides genomic content and structure divergence mirrors speciation between C. immitis and C. posadasii and has resulted in phenotypic differences noted between the species. Environmental conditions in the native geographic range of C. posadasii compared to C. immitis likely vary in many ways, including soil biochemistry, salinity, temperature, and mammalian host population. Early work on interspecific phenotypic variation showed that single isolates exhibit differential growth in response to salinity, temperature, and humidity [74,75]. Later, analyses of relatively small populations (<10 individuals) documented differences in fungal growth rates on high salt media, further suggesting that C. immitis is more salt tolerant than C. posadasii [76]. Indeed, many scientists agree that salinity, temperature, and other environmental variables strongly shape Coccidioides physiology and distribution [40, 55•, 77, 78]. The first study to interrogate phenotypic variation in a robust population of 39 C. posadasii and 46 C. immitis isolates [55•] noted that while C. posadasii and C. immitis had similar growth rates at 28°C, C. posadasii grew significantly faster at 37°C. Earlier work from the same group suggested that C. immitis produces spherules synchronously during in vitro culture where C. posadasii does not [79].
Though the two species exist in considerably different environments, and phenotypic variation in key virulence traits are currently being investigated, so far there has been no difference clinically between the species [80], and  [68,71] accordingly, currently available diagnostic tools do not differentiate at the species level. Future efforts focused on publishing robust phenotypic data and the connections to genotypic data will help the Coccidioides research community understand connections between life cycle phases spent in the environment and their relationship to virulence factors observed in clinics. Further, efforts focused on molecular diversity underpinning sporulation and dispersal dynamics, range expansion, and host affiliation will enable robust predictive modeling and inform pandemic preparedness.

Virulence Genetics
The Coccidioides genome contains~7,000-9,000 protein coding genes, and nearly half lack functional gene annotation predictions [71]. While it is clear that expansions and contractions of gene families have enabled Coccidioides and other fungi in Onygenales to target animal cell wall degradation rather than plant cell walls, functionality of the Coccidioides genome as a whole remains relatively poorly understood. It is an exciting time to be a Coccidioides genomics researcher, as the~50% of genes with annotations based on homology to known orthologs in other fungi may lack relevance due to the unique cellular structures Coccidioides produced during infections, including the spherule. As in all genome annotation endeavors, targeted gene deletion is needed to confirm functions based on computational gene annotation and functional and genomic screens. In total, less than 10 genes have been functionally characterized in Coccidioides, many of which appear to be related to virulence [81][82][83][84][85][86][87]. For example, deletion of urease gene (URE) partially reduced ammonia production and increased mice survival by 60% [88]. Further, double deletion of urease gene (URE) Ureidoglycolate hydrolase (Ugh) resulted in even lower extracellular ammonia levels and increased mice survival to 90%. These findings are supported by direct measurements, transcriptome, and volatome analyses which show that ammonia production contributes to virulence during spherule development and rupture. In another multiple gene deletion strategy, Dr. Chiung-Yu Hung et al. created a completely avirulent strain of Coccidioides as a vaccine candidate through partial deletion of chitinase genes among others (cts2/ard1/cts3 or ΔT) [83]. Loss of virulence appears to be associated with genes responsible for intracellular chitin remodeling leading to multiple changes at a transcriptional level preventing spherule rupture.
To date, all gene deletions have been completed within the C. posadasii, wildtype C735 background and one in C. posadasii strain, Silveira; therefore, intra-or interspecies virulence gene sequence variation has yet to be assessed (Table 1) [81]. However, the broad spectrum of disease symptoms in humans coupled with strong regional population genetic variation among Coccidioides isolates suggests that virulence mechanisms and severity may co-vary by species or region. Investigations by Dr. Emily Whiston showed that transcriptional patterns are generally shared between species but approximately 500 genes are differentially expressed during parasitic phase spherule growth, suggesting unique gene usage between species [73]. Phenotypic differences have been documented between species, including differential thermotolerance behavior [89], saline tolerance [76], and spherule growth patterns [79]. However, the underlying gene functions associated with these phenotypes remain largely unknown. Lewis et al. identified that mice infected with equivalent fungal inoculum had increased fungal burden and il-1β response to C. posadasii Silveira isolate but not to C. immitis 2006 or RS [90], potentially indicating hypervirulence in some isolates. Linking virulence to gene sequence and function is a top research priority. Progress in this realm is underscored by variation in the gene sequence of SOWgp (spherule outer wall protein), an extracellular glycoprotein which binds to host cells. The SOWgp deletion mutant demonstrated decreased binding in vitro and virulence in vivo. While the current SOWgp mutant was created in the C. posadasii background, molecular techniques revealed that other strains of C. posadasii showed variation in SOWgp protein size and quantity of repeats, which could potentially alter function [86], and SOWgp sequence variation within C. immitis is unknown. As previously mentioned, a successful gene editing strategy for C. immitis has not been developed, thus hindering gene function comparisons between species.
In an era of advanced genetic and genomic technologies, it may come as a surprise that such a small handful of genes have been functionally characterized and primarily in one C. posadasii isolate. Research progress in this area has been severely limited by development of genome editing tools for Coccidioides [91]. Current strategies use either introduction of linear DNA to susceptible protoplasts or Agrobacterium-mediated transformation, the latter of which appears more efficient. Challenges for efficient transformation include polynucleate arthroconidia, persistence of heterokaryons following transformation selection, and logistics of biosafety level three (BSL3) laboratory experiments [85,92]. Creation of autotrophic mutants [93] or CRISPR Cas9 [94] technologies have proven successful approaches in other fungal pathogens but have yet to be applied to Coccidioides.

Host Immune Response and Development of a Vaccine
The progress of vaccine and immunology research in the Coccidioides field is largely thanks to the women researchers in the field. There are some excellent women-led review articles highlighting the recent advances in the immune response, host-pathogen interactions, and development of a Coccidioides vaccine [95•, 96-98, 99•]. In this section, we will discuss briefly what is known about the host immune response to Coccidioides and the development of a vaccine to combat coccidioidomycosis.

Host Immune Response
The innate immune response is the first line of defense against many fungal pathogens, especially macrophages and neutrophils. Dr. Chiung-Yu Hung has shown that neutrophils are increased significantly during a Coccidioides infection [100]. Her work has shown that the role of neutrophils is not a one size fits all scenario. On one hand, mice depleted of neutrophils during a primary infection are just as susceptible as wildtype mice [101]. Mice vaccinated with a live, attenuated (ΔT vaccine) strain require neutrophils to be protected against challenge with Coccidioides. Vaccination studies have also shown an increased presence of macrophages in vaccinated mice compared to unvaccinated mice after challenge with Coccidioides [100]. Furthermore, studies show that mouse peritoneal macrophages produce tumor necrosis factor alpha, TNF-α, when stimulated with Coccidioides spherules [102]. Pattern recognition receptors (PRRs) such as toll-like receptors (TLRs) and C-type Lectin receptors interact with cell components or pathogen-associated molecular patterns (PAMPs) to detect Coccidioides [103]. Using peritoneal macrophages from wild-type and knockout mice (TLR2 -/and MyD88 -/-), studies have shown that host response to Coccidioides spherules relies on TLR2, myeloid differentiation factor 88 (MyD88), and Dectin-1 [104]. Furthermore, studies suggest that alternative splicing of Dectin-1 in C57BL/6 mice causes increased susceptibility to coccidioidomycosis [105]. Studies performed by Dr. Althea Campuzano and colleagues has shown that macrophages isolated from Dectin-1 -/-, Dectin 2 -/-, and CARD9 -/mice produced less inflammatory cytokines in response to the GCP-rCpa1 vaccine compared to wild-type mice [106•]. Additionally, these studies demonstrate less efficacy of the GCP-rCpa1 vaccine in Dectin-1 -/-, Dectin 2 -/-, and CARD9 -/mice compared to vaccinated wild-type mice. Although much remains to be done, these studies demonstrate the crucial role of the innate immune response to protect against coccidioidomycosis.
T cells have been shown to be critical for protection against coccidioidomycosis. CD4 + T cell deficiency leads to increased susceptibility to a Coccidioides infection [107]. Furthermore, CD4 + T cells differentiate into distinct lineages based on cytokines produced in response to a pathogen. A T cell helper 1 (Th1) response is associated with cytokines such as IL-12 and IFN-γ and has been shown to be important for protection against coccidioidomycosis [83,108], while a Th2-type response, activated by cytokines such as IL-4 and IL-5, has been shown to downregulate the immune response during a Coccidioides infection [83]. Th17 responses, activated by IL-17 and IL-22, have been shown to be critical for protection against coccidioidomycosis [109]. Studies to understand the host immune response to Coccidioides mainly use C. posadasii as a model and assume C. immitis to have a similar response; however, more studies are needed to discern this.

Vaccine Development
There is no clinically available vaccine against any human fungal pathogen. Interestingly, a Candida albicans vaccine, NDV-3A, demonstrates promise in clinical trials against recurrent vulvovaginal candidiasis [110], the potential to prevent colonization on medical devices [111], and even prevent against C. auris infection [112]. Many live attenuated strains have demonstrated protection against coccidioidomycosis; however, live vaccines are not preferred due to their potential safety concerns [113]. Some of the live attenuated candidates include ΔT (also known as Δcts2/ard1/cts3) [83,100,114] and ΔCPS1 [81,115]. Dr. Lisa Shubitz and colleagues are developing ΔCPS1 as a vaccine candidate to prevent infection due to C. posadasii in dogs [116]. Many studies have identified protective antigens (Pep1, Plb, Amn1, Ag2/Pra, Cs-Ag, Pmp1, Prp2, Ure, and Gel1) that could be used in a recombinant protein vaccine [117][118][119][120][121][122][123][124][125]. Although these studies demonstrated varying levels of protection, the use of multivalent vaccines shows more efficacy than a single peptide vaccine against coccidioidomycosis [117,126]. Dr. Chiung-Yu Hung and colleagues have developed a multivalent vaccine encapsulated in glucan-chitin particles, GCP-rCpa1, that has demonstrated increased survival, significantly reduced fungal burden, and showed a protective Th1 and Th17 response against C. posadasii in a murine model of coccidioidomycosis [127]. Furthermore, recent studies have shown that protection mediated by the GCP-rCpa1 vaccine is due to enhancement of Th17 responses and activation of CARD9-associated Dectin-1 and Dectin-2 signal pathways [106•]. A majority of the vaccination studies against coccidioidomycosis demonstrate protection mainly against C. posadasii infections [81, 83, 100, 106•, 114, 116, 117, 119, 122-127]. There are a couple studies that demonstrate protection against C. immitis [118,120] and only one study to demonstrate protection against both species [115] (Figure 2).

Antifungal Drugs
Antifungal medications from the triazole and polyene classes are the mainstay of treatment for coccidioidomycosis. Dr. Marley Van Dyke et al. recently summarized the agents with coverage of Coccidioides along with potential novel agents [95•]. While robust, prospective studies investigating the most appropriate treatment are lacking, fluconazole, an oral and intravenous triazole, is the most prescribed treatment and recommended as the firstline agent for primary pulmonary infection [70]. It is important to note that treatment is not always warranted, especially in the setting of uncomplicated, mild disease [70]. In cases of severe infection with dissemination and/or meningitis, amphotericin B, an intravenous polyene agent, is used as induction therapy. Amphotericin B requires intense laboratory monitoring and is typically prescribed with the aid of an infectious diseases specialist, as it can cause renal and hepatotoxicity along with infusion reactions [95•]. Investigation of novel antifungal agents for treatment of coccidioidomycosis will be crucial to expand our arsenal for disease treatment.

Conclusion
Women have pioneered Coccidioides and coccidioidomycosis research in the past, shedding light on previous large questions in the field. While numerous big questions remain regarding the environmental, genetic, and clinical aspects of this disease, it is important that the Coccidioides community continues to acknowledge and support the work of women, as well as push for further diversity and inclusion regarding this disease. Doing so will strengthen the scientific research being done on Coccidioides and likely mitigate some of the negative health outcomes from coccidioidomycosis.
Acknowledgements The authors gratefully acknowledge the contributions from women in the field of Coccidioides. Dr. Gorris thanks the Laboratory Directed Research and Development (LDRD) program and the Center for Nonlinear Studies at Los Alamos National Laboratory. Dr. Van Dyke would like to thank her sister, Sylena Measles, for helping format the figures.
Author Contribution All authors made substantial contributions to the conception and design of the review. All authors contributed to writing the manuscript and approved the final version. Data Availability Not applicable.
Code Availability Not applicable.

Declarations
Ethics Approval Not applicable.

Consent to Participate Not applicable.
Consent for Publication This work is approved for distribution under LA-UR-21-23354. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of Los Alamos National Laboratory. Los Alamos National Laboratory, an affirmative action/equal opportunity employer, is managed by Triad National Security, LLC, for the National Nuclear Security Administration of the US Department of Energy under contract 89233218CNA000001. Additional Declarations for Articles in Life Science Journals that Report the Results of Studies Involving Humans and/or Animals Not applicable.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.